Recruiting

Observational Study

Sponsor:

CHU de Quebec-Universite Laval

Code:

NCT04267484

Conditions

Memory Problems

Aging

Mild Cognitive Impairment

Shared Decision Making

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Interventions

GPS and travel diary

e-decision support platform

Study Details

Brief summary:

Most older people want to stay at home as long as possible. Effective self-management for people losing autonomy depends on reliable monitoring of their mobility, health and safety and active implication in decision-making. New technologies have the potential to provide information about changing patterns that reflect changing care needs. This information could help older adults, caregivers and health professionals to participate in decision-making about housing options when a change in living environment needs to be considered.

Conditions

Memory Problems

Aging

Mild Cognitive Impairment

Shared Decision Making

Study ID

NCT04267484

Start date

Nov 28, 2018

Status verified date

Feb, 2020

Completion date

Nov, 2021

Anticipated

Primary completion date

Aug, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Aged ≥ 65 years
  • Living at home
  • Diagnosed with mild cognitive impairment or experiencing memory issues
  • Able to read, understand and write
  • Can provide informed consent

Exclusion Criteria:

  • Older adults who are not able to provide informed consent
  • Living in nursing home or hospital

Study Design

Enrollment

294 participants

Anticipated

Interventions and Outcome Measures

Arms

Older adults with mild cognitive impairment

WP1, older adults with cognitive impairment will use a GPS tracker for 2 weeks, during which they are asked 1) to keep a daily diary about their activity (travel diary), 2) take the researcher on a walk that they often do (walking interview), and 3) participate in an in-depth interview after 2 weeks, in which their experience with the GPS ans the travel diary data are discussed.

WP2, older adults with mild cognitive impairment, caregivers, health professionals and technology developers will collaborate during group discussion meeting to co-design the e-decision support platform to be adapted.

WP3, older adults with mild cognitive impairment, caregivers and health professionals will then be asked to use the adapted e-decision support platform and fill a survey.

Interventions

GPS and travel diary

WP1: GPS tracker for 2 weeks and a daily diary about activity (travel diary).

e-decision support platform

WP2 and WP3: An e-decision support platform that will foster shared decision making about options to stay safe at home for the older adult.

Primary outcome measure

  • Autonomy and mobility assessment using GPS [ Time Frame: Participant will wear a GPS for a total of two weeks. As data collection will occur in parallel at all four sites (Quebec, Alberta, Sweden, Netherlands) data collection will happen over a period of 1 year ]
  • Iterative assessment to tailor the e-decision support technology [ Time Frame: Immediately after group discussion. 3 sequential group discussion are plan to occur, one in each country (Canada, Sweden, Netherlands) data collection will happen over a period of 1 year. ]
  • User experience assessment of the newly adapted technology [ Time Frame: Immediately after testing the new platform. As data collection will occur in parallel at all four sites (Quebec, Alberta, Sweden, Netherlands), it will happen over a period of 6 months ]

Central Contacts and Locations

Locations

CERSSPL

Recruiting

Québec, Quebec, Canada

University of Alberta

Recruiting

Edmonton, Canada

More Information

Sponsor

CHU de Quebec-Universite Laval

Last update posted

Feb 17, 2020

Last verified

Feb, 2020

Keywords

  • Shared decision making
  • Mild Cognitive Impairment
  • Technology
  • aging in place
  • memory problem

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by CHU de Quebec-Universite Laval on 2020-02-17.